These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15013043)

  • 1. Measurement of the antibiotic susceptibility of Coxiella burnetii using real time PCR.
    Boulos A; Rolain JM; Maurin M; Raoult D
    Int J Antimicrob Agents; 2004 Feb; 23(2):169-74. PubMed ID: 15013043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline.
    Rolain JM; Lambert F; Raoult D
    Ann N Y Acad Sci; 2005 Dec; 1063():252-6. PubMed ID: 16481522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
    Brennan RE; Samuel JE
    J Clin Microbiol; 2003 May; 41(5):1869-74. PubMed ID: 12734219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA gyrase and topoisomerase IV mutations in an in vitro fluoroquinolone-resistant Coxiella burnetii strain.
    Vranakis I; Sandalakis V; Chochlakis D; Tselentis Y; Psaroulaki A
    Microb Drug Resist; 2010 Jun; 16(2):111-7. PubMed ID: 20438350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.
    Raoult D; Torres H; Drancourt M
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2070-7. PubMed ID: 1759829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine susceptibility determination of Coxiella burnetii in human embryonic lung (HEL) fibroblast cells.
    Angelakis E; Khalil JB; Le Bideau M; Perreal C; La Scola B; Raoult D
    Int J Antimicrob Agents; 2017 Jul; 50(1):106-109. PubMed ID: 28478211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of axenic media to determine antibiotic efficacy against coxiella burnetii.
    Clay KA; Hartley MG; Russell P; Norville IH
    Int J Antimicrob Agents; 2018 May; 51(5):806-808. PubMed ID: 28802854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.
    Rolain JM; Maurin M; Raoult D
    Antimicrob Agents Chemother; 2001 Jan; 45(1):301-2. PubMed ID: 11120982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of rifapentine and other rifamycins against
    Miller HK; Kersh GJ
    Microbiol Spectr; 2024 Jul; 12(7):e0103424. PubMed ID: 38864598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.
    Gikas A; Spyridaki I; Scoulica E; Psaroulaki A; Tselentis Y
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3276-8. PubMed ID: 11600400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sensitive real-time PCR for specific detection and quantification of Coxiella burnetii.
    Klee SR; Tyczka J; Ellerbrok H; Franz T; Linke S; Baljer G; Appel B
    BMC Microbiol; 2006 Jan; 6():2. PubMed ID: 16423303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of effective detection method for Coxiella burnetii in mayonnaise by real-time PCR and investigation of C. burnetii contamination in commercial mayonnaise in Tokyo].
    Sadamasu K; Tabei Y; Shinkai T; Hasegawa M; Kaneko S; Hirai A; Nakama A; Ishizaki N; Odagiri M; Kamata S; Yano K; Kai A; Morozumi S
    Shokuhin Eiseigaku Zasshi; 2006 Feb; 47(1):1-8. PubMed ID: 16619850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
    Spyridaki I; Psaroulaki A; Vranakis I; Tselentis Y; Gikas A
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2690-2. PubMed ID: 19332671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibility determination for six strains of Coxiella burnetii MST 17 from Cayenne, French Guiana.
    Eldin C; Perreal C; Mahamat A; Djossou F; Edouard S; Raoult D
    Int J Antimicrob Agents; 2015 Nov; 46(5):600-2. PubMed ID: 26391379
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro susceptibility to tetracycline and fluoroquinolones of Japanese isolates of Coxiella burnetii.
    Andoh M; Naganawa T; Yamaguchi T; Fukushi H; Hirai K
    Microbiol Immunol; 2004; 48(9):661-4. PubMed ID: 15383702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin, but not pravastatin, limits in vitro infection due to Coxiella burnetii.
    Botelho-Nevers E; Espinosa L; Raoult D; Rolain JM
    J Antimicrob Chemother; 2008 Oct; 62(4):845-7. PubMed ID: 18593722
    [No Abstract]   [Full Text] [Related]  

  • 17. The Effect of pH on Antibiotic Efficacy against Coxiella burnetii in Axenic Media.
    Smith CB; Evavold C; Kersh GJ
    Sci Rep; 2019 Dec; 9(1):18132. PubMed ID: 31792307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient method of cloning the obligate intracellular bacterium Coxiella burnetii.
    Beare PA; Howe D; Cockrell DC; Heinzen RA
    Appl Environ Microbiol; 2007 Jun; 73(12):4048-54. PubMed ID: 17468273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones.
    Lever MS; Bewley KR; Dowsett B; Lloyd G
    Int J Antimicrob Agents; 2004 Aug; 24(2):194-6. PubMed ID: 15288324
    [No Abstract]   [Full Text] [Related]  

  • 20. Phagolysosomes of Coxiella burnetii-infected cell lines maintain an acidic pH during persistent infection.
    Maurin M; Benoliel AM; Bongrand P; Raoult D
    Infect Immun; 1992 Dec; 60(12):5013-6. PubMed ID: 1452331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.